Related Experiment Videos
Comparative activity of ciprofloxacin against anaerobic bacteria
Antimicrobial Agents and Chemotherapy
|March 1, 1985
Abstract:
The in vitro activity of ciprofloxacin was assessed against 362 strains of anaerobic bacteria and compared with that of cefoxitin, clindamycin, metronidazole, and mezlocillin. Only 31% of the strains tested were susceptible to ciprofloxacin. The other agents were active against most of the strains tested.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Local review of treatment of hand enchondroma (artificial bone substitute versus autologous bone graft) in a tertiary referral centre: 13 years' experience.
Hong Kong medical journal = Xianggang yi xue za zhi·2015
Exocellular phospholipase C activity from a Propionibacterium acnes strain isolated from a periodontal pocket.
Journal of periodontology·1997
Comparative activity of SCH 34343 against anaerobic bacteria.
Diagnostic microbiology and infectious disease·1986
Establishment of MICs of moxalactam for control and reference anaerobic organisms in agar dilution and microdilution techniques.
Antimicrobial agents and chemotherapy·1985
Anaerobes as normal oral flora.
Reviews of infectious diseases·1984
Phage-first treatment results in subpopulation-driven collateral sensitivity to beta-lactams in an extensively drug-resistant Pseudomonas aeruginosa.
Antimicrobial agents and chemotherapy·2026
Population pharmacokinetics of piperacillin/tazobactam in critically ill pediatric patients.
Antimicrobial agents and chemotherapy·2026
XAB06, a glyco-humanized broad-spectrum anti-Pseudomonas aeruginosa polyclonal antibody, protects mice in a lethal sepsis model.
Antimicrobial agents and chemotherapy·2026
In vitro activity profiles and temporal trends in reduced susceptibility to azoles in Coccidioides in the United States.
Antimicrobial agents and chemotherapy·2026
Impact of renal impairment on pharmacokinetics, safety, and tolerability of funobactam, combined with imipenem and cilastatin.
Antimicrobial agents and chemotherapy·2026
In vitro carbapenem activity in Neisseria gonorrhoeae.
JAC-antimicrobial resistance·2026
Mechanistic Investigations of a Novel Lactam Antifungal Agent Against Candida albicans.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica·2026
Aggregicoccus is a myxobacterial genus inherently deficient in fruiting genes.
Microbiology spectrum·2026
In vitro antibacterial and concentration-dependent bactericidal effects of Terminalia arjuna extract against Staphylococcus aureus and methicillin-resistant Staphylococcus aureus, with synergistic activity against methicillin-resistant Staphylococcus aureus.
Journal of advanced pharmaceutical technology & research·2026